trending Market Intelligence /marketintelligence/en/news-insights/trending/qsHBV4sl1op9sdt0MGfS-Q2 content esgSubNav
In This List

Xenetic appoints 3 directors

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Xenetic appoints 3 directors

Adam Logal, James Callaway and Dmitry Genkin joined Xenetic Biosciences Inc.'s board.

Logal is the senior vice president, CFO, chief accounting officer and treasurer of Opko Health Inc. Callaway serves as a corporate strategy consultant at Callaway Innovations.

Genkin is chairman of PJSC Pharmsynthez and previously served on the company's board from 2004 to 2016.